PWP
ECYT

Private Wealth Partners’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Private Wealth Partners’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,000
Closed -$61K – 178
2014
Q3 		$61K Sell
10,000
-5,000
-33% -$34.1K 0.01% 167
2014
Q2 		$99K Buy
+15,000
New +$169K 0.02% 151

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Private Wealth Partners's ECYT Position: Q4 2014 in Review

Private Wealth Partners sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2014, closing a stake of 10,000 shares — an estimated $61K sold.

Private Wealth Partners first reported a position in ECYT in Q2 2014 and held it in 2 quarters. The position peaked at $99K in Q2 2014. 100 funds tracked by Wall St. Rank hold ECYT as of Q4 2014.

  • Private Wealth Partners reported no remaining Endocyte, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Private Wealth Partners sold 10,000 Endocyte, Inc. Common Stock shares in Q4 2014, an estimated $61K.
  • Private Wealth Partners first reported a position in Endocyte, Inc. Common Stock in Q2 2014 and held it in 2 quarters.
  • Private Wealth Partners's Endocyte, Inc. Common Stock position peaked at $99K in Q2 2014.
  • 100 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2014.

Based on Private Wealth Partners's 13F filing for Q4 2014, filed 23 Jan 2015.